Literature DB >> 19059505

Effect of increasing vertebral marrow fat content on BMD measurement, T-Score status and fracture risk prediction by DXA.

G M Blake1, J F Griffith, D K W Yeung, P C Leung, I Fogelman.   

Abstract

Quantitative examination of iliac crest bone biopsies shows that as subjects become older bone and functional marrow are replaced by adipose tissue. Studies of vertebral marrow fat using nuclear magnetic resonance spectroscopy ((1)H-MRS) show that subjects with lower spine T-scores have significantly higher marrow fat content. These findings suggest that the ability of DXA scans to determine fracture risk may be partly explained by the effect of increased marrow fat on BMD. However, a proper evaluation of the relationship between WHO spine T-score status and marrow fat content requires that the BMD data are first corrected for the bias caused by a selection effect in which subjects with higher marrow fat are more likely to be identified as having osteoporosis. In this study we have therefore reanalysed previously published data for 185 elderly Hong Kong Chinese subjects (103 women, mean age 73 y; 82 men, mean age 73 y) who had spine DXA scans and (1)H-MRS measurements of L3 marrow fat. The effect of varying marrow fat on BMD was modelled using vertebral body thicknesses measured in 50 men and women. Spine T-scores in each individual were adjusted for the measured marrow fat. Subjects were assigned to WHO categories based on their corrected T-scores, and the relationship between marrow fat and T-score status evaluated using regression analysis and analysis of variance. The average change in percent marrow fat per T-score unit was used to infer the fraction of the spine BMD fracture discrimination explained by marrow composition. The mean (SD) of the L1-L4 vertebral body thickness was 30.2 (2.1) mm for Hong Kong women and 33.4 (2.5) mm for men. A change in marrow fat content from 0 to 100% was estimated to produce a BMD decrease of 0.14 g/cm(2) (1.3 T-score units) in women and 0.16 g/cm(2) (1.3 T-score units) in men. Although adjusting spine BMD for marrow fat reduced the significance of the correlation, there was still a trend for marrow fat to increase with decreasing T-score with a slope of -1.2+/-0.7% per T-score unit (p=0.078) for women and -1.4+/-0.6% per T-score unit (p=0.023) for men. When the effect of marrow composition on fracture discrimination was evaluated the results showed that the higher vertebral marrow fat content found in osteoporotic subjects made a negligible contribution to the ability of spine BMD measurements to predict fracture risk.

Entities:  

Mesh:

Year:  2008        PMID: 19059505     DOI: 10.1016/j.bone.2008.11.003

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  26 in total

1.  Relationship between MRI-measured bone marrow adipose tissue and hip and spine bone mineral density in African-American and Caucasian participants: the CARDIA study.

Authors:  Wei Shen; Rebecca Scherzer; Madeleine Gantz; Jun Chen; Mark Punyanitya; Cora E Lewis; Carl Grunfeld
Journal:  J Clin Endocrinol Metab       Date:  2012-02-08       Impact factor: 5.958

Review 2.  New advances in imaging osteoporosis and its complications.

Authors:  James F Griffith; Harry K Genant
Journal:  Endocrine       Date:  2012-05-23       Impact factor: 3.633

3.  Sensitivity and specificity assessment of DWI and ADC for the diagnosis of osteoporosis in postmenopausal patients.

Authors:  Mohammad Momeni; Mohammad Asadzadeh; Karim Mowla; Mohammad Ghasem Hanafi; Mohammad Momen Gharibvand; Aliakbar Sahraeizadeh
Journal:  Radiol Med       Date:  2019-09-17       Impact factor: 3.469

4.  Quantification of vertebral bone marrow fat content using 3 Tesla MR spectroscopy: reproducibility, vertebral variation, and applications in osteoporosis.

Authors:  Xiaojuan Li; Daniel Kuo; Anne L Schafer; Anne Porzig; Thomas M Link; Dennis Black; Ann V Schwartz
Journal:  J Magn Reson Imaging       Date:  2011-04       Impact factor: 4.813

5.  Unsaturation level decreased in bone marrow fat of postmenopausal women with low bone density using high resolution magic angle spinning (HRMAS) 1H NMR spectroscopy.

Authors:  Xiaojuan Li; Keerthi Shet; Kaipin Xu; Juan Pablo Rodríguez; Ana María Pino; John Kurhanewicz; Ann Schwartz; Clifford J Rosen
Journal:  Bone       Date:  2017-08-18       Impact factor: 4.398

6.  Treadmill training prevents bone loss by inhibition of PPARγ expression but not promoting of Runx2 expression in ovariectomized rats.

Authors:  Yongjie Chen; Shouhui Wang; Shumin Bu; Yingjie Wang; Yushuang Duan; Shaofeng Yang
Journal:  Eur J Appl Physiol       Date:  2011-01-09       Impact factor: 3.078

7.  Effect of zoledronic acid on vertebral marrow adiposity in postmenopausal osteoporosis assessed by MR spectroscopy.

Authors:  Yi Yang; Xianfu Luo; Fuhua Yan; Zheng Jiang; Yong Li; Chen Fang; Junkang Shen
Journal:  Skeletal Radiol       Date:  2015-07-01       Impact factor: 2.199

8.  Does vertebral bone marrow fat content correlate with abdominal adipose tissue, lumbar spine bone mineral density, and blood biomarkers in women with type 2 diabetes mellitus?

Authors:  Thomas Baum; Samuel P Yap; Dimitrios C Karampinos; Lorenzo Nardo; Daniel Kuo; Andrew J Burghardt; Umesh B Masharani; Ann V Schwartz; Xiaojuan Li; Thomas M Link
Journal:  J Magn Reson Imaging       Date:  2011-08-16       Impact factor: 4.813

9.  High bone marrow fat in patients with Cushing's syndrome and vertebral fractures.

Authors:  Francesco Ferraù; Salvatore Giovinazzo; Erika Messina; Agostino Tessitore; Sergio Vinci; Gherardo Mazziotti; Andrea Lania; Francesca Granata; Salvatore Cannavò
Journal:  Endocrine       Date:  2019-08-02       Impact factor: 3.633

10.  Vertebral bone marrow fat associated with lower trabecular BMD and prevalent vertebral fracture in older adults.

Authors:  Ann V Schwartz; Sigurdur Sigurdsson; Trisha F Hue; Thomas F Lang; Tamara B Harris; Clifford J Rosen; Eric Vittinghoff; Kristin Siggeirsdottir; Gunnar Sigurdsson; Diana Oskarsdottir; Keerthi Shet; Lisa Palermo; Vilmundur Gudnason; Xiaojuan Li
Journal:  J Clin Endocrinol Metab       Date:  2013-04-03       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.